Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

picture of

Breaking News

Thermo Fisher Scientific launches Next-Generation of Mass Spectrometry-based solutions at virtual summit

The new systems and software tools support scientists working across a wide range of applications, from proteomics ...

Avantor acquires RIM Bio to expand single-use business into China

Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical ...

Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Lessons learned from the COVID-19 pandemic

As vaccines roll out and COVID-19 cases begin to decline, Amélie Boulais, Head of Market Entry Strategy for Virus ...

Thermo Fisher launches first cleanroom-compatible CO2 incubator for cell culture

Thermo Fisher has designed the cell growth incubator with in-chamber HEPA filtration, on-demand 180°C sterilisation ...

Sartorius to open manufacturing facility in Hampshire

With the Havant facility, Sartorius now has five locations in the UK, employing over 900 staff members

Bispecific antibodies in review: from cell line development to manufacturing

With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...

From dark art to an age of enlightenment

Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...

Why the production of bispecific antibodies depends on early stage product characterisation

Chloe Ackaert, Senior Scientist, and Sofie Pattijn, Chief Technology Officer and founder, ImmunXperts a Nexelis group ...

Moderna and Catalent announce expanded vaccine collaboration

In September 2020, Catalent announced a $50 m investment into the third high-speed vial filling line at Bloomington. ...

Azzur completes second ready-to-use cleanroom facility in San Diego

US-based Azzur Cleanrooms on Demand has announced the completion of a build in San Diego that is the group's second ...